Angiogenesis inhibitory agent

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5142315, 514252, 514278, 514397, 514409, 549332, A61K 31335, C07D40708

Patent

active

056985860

ABSTRACT:
O-substituted fumagillol derivatives and its salts have an angiogenesis inhibiting activity and are useful for prophylaxis and treatment of diseases induced by abnormally stimulated neovascularization.

REFERENCES:
patent: 4954496 (1990-09-01), Oku et al.
patent: 5135919 (1992-08-01), Folkman et al.
Chemical Abstracts, vol. 70, No. 9, 3rd Mar. 1969, p. 206, Abstract No. 36365g, Columbus, Ohio, US; M.M. Maevskii, et al.
Chemical Abstracts, vol. 106, No. 21, 25th May 1987, p. 706, Abstract No. 176153y, Columbus, Ohio, US; & JP-A-62 00 476 (Fujisawa Pharmaceutical Co., Ltd.).
Derwent Printout from Dialog of the abstract corresponding to Japanese Kokai Tokkyo Koho No. 58-131978 (1983).
Derwent Printout from Dialog of the abstract corresponding to Japanese Kokai Tokkyo Koho No. 63-119500 (1988).
S. Taylor, et al., Nature, 297:307 (1982).
J. Folkman, et al., Science, 221:719 (1983).
D. Tarbell, et al., J. Am. Chem. Soc. 83:3096 (1961).
O. Mitunobu, Synthesis, (1981), 1, pp. 1-28.
I. Sutherland (Ed.), "Comprehensive Organic Chemistry", vol. 2, pp. 4-11, Pergamon Press (1979).
Gimbrone, et al., J. National Cancer Institute, 52:413-419 (1974).
J. Ross, et al., J. Am. Chem. Soc., 78:4675 (1956).
Falk, et al., J. Immunol. Meth., 33:239-247 (1980).
Folkman, et al., Science, 230:1375 (1985).
Chemical Patent Index, Basic Abstracts Journal Section B, Week 8706, Abstract No. 87-040948/06, Abstract of JP-A-476/1987.
J. DiPaolo, et al., Antibiotics Annual, 1958-1959, pp. 541-546.
G. Ruecker, et al. Chemical Abstracts, 77:29f (1972).
The Merck Index, 11th Ed., (1989) pp. 670-671; Compound No. 4199-Fumagillin .

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Angiogenesis inhibitory agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Angiogenesis inhibitory agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiogenesis inhibitory agent will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-206776

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.